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ABSTRACT 
As per world health organization by 2020, the number of tuberculosis infected patients will be 25% of the world population. Now, it is challenging 
and essential target for medicinal chemists in drug search for tuberculosis. Hence the present work includes synthesis of a s eries of 3,5-
disubstituted thiazolidine-2,4-dione derivatives by condensation of thiazolidine-2,4-dione with aromatic aldehydes at 5th position-Knoevenagel 
reaction followed by condensation of these 5-substituted thiazolidine-2,4-diones by using various aromatic and alkali halides at 3rd position yielding 
to 3,5-disubstituted thiazolidine-2,4-diones. The synthesized 3,5-disubstituted thiazolidine-2,4-dione compounds were characterized by IR, 1H NMR, 
Mass spectroscopy and CHNO Elemental analysis. The synthesized compounds were predicted for biological activities by using Prediction of Activity 
Spectra for Substances computerized program-(Insilico method) based on those results the compounds were screened against Mycobacterium 
tuberculosis H37RV strain in the Middlebrook 7H9 broth by microplate alamar blue assay using Streptomycin and Pyrazinamide as standard drugs. 
The results revealed that among those synthesized new 3,5-disubstituted thiazolidinediones 3a, 3b, 3e and 3h were showed good antitubercular 
activity.  
Keywords: Thiazolidine-2,4-dione, knoevenagel reaction, Mycobacterium tuberculosis, antitubercular activity. 
INTRODUCTION 
Currently, the treatment for tuberculosis diseases still remains an 
important and challenging problem because of emerging resistance 
to current regimen and also appearance of drug-resistant strains in 
tuberculosis like mycobacterium tuberculosis H37RV strain. Now, it is 
challenging and essential target for medicinal chemists in drug 
search for treatment of tuberculosis. From the literature survey 
reveals that 1,3-thiazolidine-2,4-dione class of chemical products 
were associated with interesting biological and pharmacological 
activities [1,2] such as antidiabetic activity[3-5], aldose reductase 
inhibitory activity[6,7], antimicrobial activity[8,9], anti-
inflammatory activity[10], oncostatic[11], anti-cancer 
activity[12,13] and tuberculostatic[14]. The present work designed 
and developed to synthesize some new compounds with significant 
medicinal value. Here we reported the synthesis and 
characterization of various 3,5-disubstituted thiazolidine-2,4-diones. 
These compounds screened for their antitubercular activity against 
mycobacterium tuberculosis H37RV. 
MATERIALS AND METHODS 
Melting points of the synthesized compounds were determined in an 
open capillary tube using digital melting point apparatus and are 
uncorrected. The purity of the compounds were established by thin 
layer chromatography by using pre-coated silica gel strips, 
chloroform and acetone (1:2) as solvent system and iodine vapors as 
visualizing agent. Infrared spectra (υ cm-1) were recorded on a 
SHIMADZU FT-IR 4000 using KBr disks. CHNO elemental analysis 
carried by Perkin Elmer Series II 2400 CHNS/O Elemental analyzer. 
Mass spectra were obtained on JEOL GC mate II GC- Mass 
spectrometer at 70ev using direct insertion probe method. NMR 
spectra were taken on BRUKER AV400-400MHz High Resolution 
Multinuclear FT – NMR spectrometer by using TMS as internal 
standard and the solvent used was DMSO.  
EXPERIMENTAL WORK 
To synthesize a series of 3,5-disubstituted thiazolidine-2,4-diones, 
first start with the preparation of thiazolidine-2,4-dione (1)              
by     treating   chloro  acetic     acid  with  thiourea   by using HCl. The  
 
 
synthesized thiazolidine-2,4-dione reacted with aromatic aldehydes 
at 5th position (Knoevenagel reaction) gives 5- substituted 
thiazolidine-2,4-diones (2a-c). Finally these 5-substituted 
thiazolidine-2,4-diones condensed by using various aromatic and 
alkali halides  yielding to 3,5-disubstituted thiazolidine-2,4-diones 
(3a-i). Completion of the reactions was determined by thin layer 
chromatography chloroform and acetone as solvent system and 
iodine vapors as visualizing agent. 
General procedure for the synthesis of 2,4-Thiazolidinedione 
(1): 
Dissolve chloroacetic acid (56.5g, 0.6mol) in 30mL of water and 
thiourea (45.6g, 0.6mol) in 30mL of water then these solutions were 
mixed and the mixture was stirred for 15 min to obtain a white 
precipitate, accompanied by considerable cooling. Then add 30mL of 
conc. HCl from a dropping funnel slowly to the content of flask. After 
which the reaction mixture was refluxed for 10hrs. On cooling, the 
contents of the flask solidified into a cluster of white needles and 
product was filtered and washed with water to remove traces of 
hydrochloric acid and dried, purified by recrystallization with ethyl 
alcohol.   
General procedure for the synthesis of 5-substituted-1,3-
thiazolidine-2,4-dione (2a-c):  
A mixture of 2,4-thiazolidinedione 1 (11.7g, 0.1mol), aldehyde 
(0.1mol), glacial acetic acid (50mL) and fused sodium acetate (1.8g) 
was refluxed for 1 hr with occasional shaking. Cool, then the reaction 
mixture was poured in water (500mL), the product obtained was 
filtered, washed with water, alcohol and ether and was recrystallized 
with glacial acetic acid. [15]  
1,3-thiazolidinedione-2,4-dione 1: 
Compound (1) analyzed for C3H3O2NS, Yield was 93% & m.p. 123-
1250C. IR (υ cm-1) spectrum showed characteristic bands 619.23 (C-
S), 1265.46 (C-N), 1749.65 (C=O), 3356.55 (N-H), 1776.66 (CO-NH-
CO). 
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Various coupling components (R and R1) in 3a-i: 

















































































Where X = Cl (3b, 3c, 3d, 3e, 3g, 3h, 3i); X = Br (3a, 3f).  
5-(4-methoxybenzylidene)-1, 3-thiazolidine-2,4-dione (2a): 
Compound (2a) analyzed for C3H3O2NS, Yield-82% & m.p. 254-
2580C. IR (υ cm-1) spectrum showed characteristic bands 628.87 (C-
S), 1331.04 (C-N), 1751.58 (C=O), 3335.33 (N-H), 1670.56 (C=C), 
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1873.11 (C-H aromatic out of plane summation bands), 1251.95 (C-
O), 2972.67 (C-H str), 2833.78 (C-H of OCH3), 1466.08 (C-H def). 
5-[4-(dimethyl amino)benzylidene]-1,3-thiazolidine-2,4-dione 
(2b): 
Compound (2b) analyzed for C3H3O2NS, Yield-82% & m.p 254-2580C. 
IR (υ cm-1) spectrum showed characteristic bands 626.94 (C-S), 
1269.32, 1334.90 (C-N), 1724.57 (C=O), 3317.97 (N-H), 1658.98 
(C=C), 1875.04 (C-H aromatic out of plane summation bands), 
2968.81 (C-H str), 1433.28 (C-H def). 
5-benzylidene-1,3-thiazolidine-2,4-dione (2c): 
Compound (2c) analyzed for C3H3O2NS, Yield-82% & m.p 254-2580C. 
IR (υ cm-1) spectrum showed characteristic bands 634.66 (C-S), 
1290.53, 1334.90 (C-N), 1738.07 (C=O), 3319.90 (N-H), 1672.49 
(C=C), 1846.10, 1934.84 (C-H aromatic out of plane summation 
bands), 3032.47 (C-H). 
General procedure for the synthesis of 3,5-disubstituted-1,3-
thiazolidine-2,4-dione (3a-i): 
A mixture of 5-substituted-1,3-thiazolidine-2,4-dione (2.35g, 
0.01mol), aromatic/alkyl halide (0.01mol) and ethanol (20mL) was 
refluxed for 3-4hrs at 30-40°C. Then the reaction mixture was 
cooled, poured in crushed ice, the solid separated was filtered, 
recrystallized with ethanol.[16] 
3-(4-aminophenyl)-5-(4-methoxybenzylidene)-1,3-thiazolidine-
2,4-dione (3a): 
Yield-78%, m.p. 275-2800C; IR (υ cm-1) spectrum showed 
characteristic bands at 628.87 (C-S), 1307.54 (C-N), 1277.03 (aryl-
O), 1458.36 (C-H def), 1734.22 (C=O), 1670.56 (C=C), 1844.17, 
1902.04 (C-H aromatic out of plane summation bands), 2970.74 (C-
H str), 2812.56 (C-H of OCH3); 1H NMR (400MHz, DMSO) δ 3.8 (3H, 
s, OCH3), δ 7.0-7.6 (8H, m, aromatic protons), δ 3.295 (2H, s, NH2), δ 
7.537 (1H, s, CH); Mass m/z 326.44; Anal. Calcd for C17H14N2O3S: C, 




Yield-92%, m.p. 282-2860C; IR (υ cm-1) spectrum showed 
characteristic bands 628.87 (C-S), 1317.54 (C-N), 1278.96 (aryl-O), 
1458.36 (C-H def), 1732.29 (C=O), 1670.56 (C=C), 1844.17, 1929.05 
(C-H aromatic out of plane summation bands), 2970.74 (C-H str), 
2808.70 (C-H of OCH3), 1508.52 ( C-NO2); 1H NMR (400MHz, DMSO) 
δ 3.81 (3H, s, OCH3), δ 7.0-7.6 (7H, m, aromatic protons), δ 3.301 
(2H, s, NH2), δ 7.74 (1H, s, CH); Mass m/z 371.07; Anal. Calcd for 
C17H13N3O5S: C, 54.98; H, 3.53; N, 11.31; O, 21.54. Found: C, 54.96; H, 
3.54; N, 11.29; O, 21.58.  
3-tert-butyl-5-(4-methoxybenzylidene)-1,3-thiazolidine-2,4-
dione (3c): 
Yield-64%, m.p. 225-2300C; IR (υ cm-1) spectrum showed 
characteristic bands 628.87 (C-S), 1317.54 (C-N), 1394.70 (C-H def), 
1732.29 (C=O), 1672.49 (C=C), 1838.39, 1965.70 (C-H aromatic out 
of plane summation bands), 2872.36 (C-H str), 2814.48 (C-H of 
OCH3); Mass m/z 291.18; Anal. Calcd for C15H17NO3S: C, 61.83; H, 
5.88; N, 4.81; O, 16.47. Found: C, 61.78; H, 5.85; N, 4.83; O, 16.44.  
3-(2-amino-5-nitrophenyl)-5-[4-(dimethylamino)benzylidene]-
1,3-thiazolidine-2,4-dione (3d): 
Yield-88%, m.p. 305-3100C; IR (υ cm-1) spectrum showed 
characteristic bands 640.44 (C-S), 1379.27, 1261.60 (C-N 30, 10), 
1441.00 (C-H def), 1724.57 (C=O), 1626.19 (C=C), 1878.90, 1925.19 
(C-H aromatic out of plane summation bands), 2959.16 (C-H str), 
3497.37 (N-H), 1554.81 (C-NO2); Mass m/z 384.10; Anal. Calcd for 
C18H10N4O4S: C, 56.24; H, 4.20; N, 14.57; O, 16.68. Found: C, 56.26; H, 
4.21; N, 14.55; O, 16.68. 
4-{5-[4-(dimethyl amino) benzylidene]-2,4-dioxo-1,3-
thiazolidin-3-yl}benzaldehyde (3e): 
Yield-74%, m.p. 268-2740C; IR (υ cm-1) spectrum showed 
characteristic bands 626.94 (C-S), 1334.90 (C-N), 1433.28 (C-H def), 
924.02 (C-H def of CHO), 1726.50 (C=O), 1658.98 (C=C), 1795.95, 
1822.95 (C-H aromatic out of plane summation bands), 2972.67 (C-
H str), 1689.85 (aryl-C=O); 1H NMR (400MHz, DMSO) δ 3.003 (6H, s, 
CH3) δ 6.7-7.7 (8H, m, aromatic protons) δ 9.659 (1H, s, CHO) δ 7.918 
(1H, s, CH); Mass m/z 352.28; Anal. Calcd for C19H16N2O3S: C, 64.76; 
H, 4.58; N, 7.95; O, 13.62 . Found: C, 64.79; H, 4.61; N, 7.92; O, 13.60.  
3-(4-acetylphenyl)-5-[4-(dimethyl amino) benzylidene]-1,3-
thiazolidine-2,4-dione (3f): 
Yield-77%, m.p. 272-2760C; IR (υ cm-1) spectrum showed 
characteristic bands 644.30 (C-S), 1371.55 (C-N of 30), 1456.43 (C-H 
def of CH3), 1740.00, 1726.50 (C=O), 1658.98 (C=C), 1865.39 (C-H 
aromatic out of plane summation bands), 2951.45 (C-H), 2907.08 (C-
H of CH3-CO); 1H NMR (400MHz, DMSO) δ 2.979 (6H, s, CH3) δ 6.8-
7.7 (8H, m, aromatic protons) δ 2.494 (3H, s, CO-CH3) δ 7.466 (1H, s, 
CH); Mass m/z 366.36; Anal. Calcd for C20H18N2O3S: C, 65.55; H, 4.95; 
N, 7.64; O, 13.10. Found: C, 65.58; H, 4.93; N, 7.68; O, 13.08. 
3-(amino acetyl)-5-[4-(dimethyl amino) benzylidene]-1,3-
thiazolidine-2,4-dione (3g): 
Yield-69%, m.p. 235-2400C; IR (υ cm-1) spectrum showed 
characteristic bands 632.73 (C-S), 1336.83, 1313.68 (C-N str of 30, 
10), 1458.36 (C-H def of CH3), 1471.87 (C-H def of  CH2), 1724.57 
(C=O), 1660.91 (C=C), 1844.17 (C-H aromatic out of plane 
summation bands), 2941.80 (C-H), 3385.48 (N-H); Mass m/z 305.02; 
Anal. Calcd for C14H15N3O3S: C, 55.07; H, 4.95; N, 13.76; O, 15.72. 
Found: C, 55.12; H, 4.98; N, 13.74; O, 15.76. 
3-(2-amino-5-nitrophenyl)-5-benzylidene-1,3-thiazolidine-2,4-
dione (3h): 
Yield-84%, m.p. 290-2950C; IR (υ cm-1) spectrum showed 
characteristic bands 634.66 (C-S), 1317.54 (C-N), 1749.65 (C=O), 
1672.49 (C=C), 1844.17, 1896.26 (C-H aromatic out of plane 
summation bands), 2895.50 (C-H), 3487.72 (N-H), 1491.16 (C-NO2); 
1H NMR (400MHz, DMSO) δ 6.7-8.25 (8H, m, aromatic protons) δ 
4.757 (2H, s, NH2) δ 7.859 (1H, s, CH); Mass m/z 341.71; Anal. Calcd 
for C16H11N3O4S: C, 56.30; H, 3.25; N, 12.31; O, 18.75. Found: C, 56.32; 




Yield-54%, m.p. 335-3400C; IR (υ cm-1) spectrum showed 
characteristic bands 632.73 (C-S), 1336.83 (C-N), 1458.36 (C-H def), 
1740.00 (C=O), 1672.49 (C=C), 1871.18, 1925.19 (C-H aromatic out 
of plane summation bands), 2916.72 (C-H str), 3325.68 (N-H); Mass 
m/z 594.13; Anal. Calcd for C32H30N6O4S: C, 64.63; H, 5.08; N, 14.13; 
O, 10.76. Found: C, 64.67; H, 5.06; N, 14.12; O, 10.78. 
Prediction of biological activity: 
Prediction of Activity Spectra for Substances (PASS) is a software 
product designed as a tool for evaluating the general biological 
potential of an organic drug-like molecule. It operates with many 
thousands of substances from the training set, and provides more 
objective estimation. PASS compares the structure of a new 
compound with structures of well known biologically active 
substance and therefore it is possible to estimate if a new compound 
may have a particular effect. So, all the title compounds SMILES 
notations were entered in PASS software, among those possible 
biological activities the compounds showed more probability to be 
active for anti-inflammatory, anti-tuberculosic and antidiabetic [17]. 
Data presented in table 1. 
Table 1: Predicted biological activities by PASS 
Code Antidiabetic anti-inflammatory anti-tuberculosic 
Pa Pi Pa Pi Pa Pi 
3a 0.594 0.006 0.683 0.014 0.473 0.015 
3b 0.507 0.015 0.522 0.046 0.442 0.021 
3c 0.724 0.004 0.529 0.044 0.405 0.031 
3d 0.476 0.019 0.683 0.014 0.473 0.015 
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3e 0.567 0.008 0.577 0.030 0.432 0.023 
3f 0.580 0.007 0.721 0.010 0.308 0.066 
3g 0.688 0.005 0.364 0.145 0.334 0.053 
3h 0.535 0.011 0.519 0.047 0.440 0.021 
3i 0.497 0.016 0.413 0.106 --- --- 
Pa = probability "to be active"; Pi = probability "to be inactive" 
Antitubercular activity 
The anti mycobacterial activity of synthesized compounds were 
assessed against M. tuberculosis H37Rv using Microplate Alamar Blue 
Assay (MABA). This methodology is non-toxic, uses a thermally 
stable reagent and shows good correlation with proportional and 
BACTEC radiometric methods. 200µL of sterile de-ionized water was 
added to all outer perimeter wells of sterile 96 wells plate to 
minimize evaporation of medium in the test wells during incubation. 
The 96 wells plate received 100µL of the Middle brook 7H9 broth 
and serial dilution of compounds were made directly on plate. The 
final drug concentrations tested were 100 to 0.2 µg/ml. Plates were 
covered and sealed with parafilm and incubated at 37ºC for five 
days. At the end of 5th day, 25µL of freshly prepared 1:1 mixture of 
Alamar blue reagent and 10% tween 80 was added to the plate and 
incubated for 24 hrs. A blue color in the well was interpreted as no 
mycobacterial growth, and pink color was scored as growth. The 
MIC was defined as lowest drug concentration which prevented the 
color change from blue to pink. [17]. Results were shown in table 2. 
RESULTS AND DISCUSSION 
In the present work, all the title compounds 3,5-disubstituted 
thiazolidine-2,4-diones (3a-i) were synthesized in mild conditions 
and yields were satisfactory. The reaction led to the expected 
products; however they were purified by recrystallization from 
suitable solvents. The synthesized compounds were characterized 
by IR, 1H NMR, Mass and elemental analysis. Then antitubercular 
activity of the synthesized compounds was screened against 
Mycobacterium tuberculosis H37RV strain. 
Table 2: Anti-tubercular activity of synthesized compounds       
(3a-i) 
























From the results of the anti-tubercular activity revealed that the 
synthesized 3,5-disubstituted thiazolidine-2,4-diones exhibited 
activity at concentrations ranging from 12.5 to 100µg/mL. It is clear 
from the results that the substitution at 3rd position i.e., at N atom in 
thiazolidinedione by arylation may exhibit marked activity and 
having electron releasing groups like dimethyl amino and methoxy 
groups at para position of benzylidene at 5th position of the 
thiazolidinediones may also enhance the activity. In particular, 
compounds 3a, 3b, 3e and 3h having substituted phenyl rings with 
amino, aldehyde and nitro groups showed more activity 
(12.5µg/mL). Rest of the compounds exhibited moderate to mild 
activity. Our findings may have an impact on further investigations 
in this field in search of potent antitubercular agents. 
CONCLUSION 
In the present study, some new 3,5-disubstituted thiazolidinedione 
derivatives were synthesized, characterized by IR, 1H NMR, Mass 
spectroscopy and CHNO Elemental analysis. All the synthesized 
compounds show characteristic absorption peaks in IR and NMR 
spectra.  
The synthesized compounds were evaluated for anti-tubercular 
activity by Microplate alamar blue assay (MABA).  The results 
revealed that the synthesized new 3,5-disubstituted 
thiazolidinediones showed good anti-tubercular activity having 
electron releasing groups like dimethyl amino and methoxy groups 
at para position of phenyl rings at 5th position exhibited relatively 
marked activity and also N-arylation shows better activity. The study 
revealed the necessity of synthesizing many more compounds 
having other electron releasing substituents. Such compounds may 
emerge as much more potent anti-tubercular agents. 
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